Atlas FDA

NAJ

8 FDA 510(k) clearances · Product code

180 daysmedian time to decision
271 days90th percentile
8clearances measured

FDA profile

Official device name
Agents, Embolic, For Treatment Of Uterine Fibroids
Device class
Class II (moderate risk)
Regulation
21 CFR 870.3300
Medical specialty
Cardiovascular
Flags
Implant
Adverse events (MAUDE)
2013: 9 · 2014: 15 · 2015: 16 · 2016: 14 · 2017: 11 · 2022: 20
Reports received by FDA, not confirmed device causation - volume tracks device popularity as much as risk.
Sort:Newest firstOldest first

Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free

RecordFirmDate
Bearing nsPVA Express™ (K233813)Merit Medical Systems, Inc.2023-12-21
CalliSpheres Embolic Microspheres, 8Spheres Embolic Microspheres (K173871)Suzhou Hengrui Callisyn Biomedical Co., Ltd.2018-09-17
EMBOZENE COLOR-ADVANCED MICROSPHERES, EMBOZENE OPAQUE (NON-COLORED) MICROSPHERES (K133447)Celonova Biosciences, Inc.2014-02-24
BEARING NSPVA EMBOLIZATION PARTICLES (K130259)Merit Medical Systems, Inc.2013-06-07
CONTOUR EMBOLIZATION PARTICLES, MODELS M0017600121, M0017600221, M0017600321 (K100663)Boston Scientific Corporation2010-04-16
COOK INCORPORATED POLYVINYL ALCOHOL FOAM EMBOLIZATION PARTICLES (K081768)Cook Incorporated2008-12-23
CONTOUR EMBOLI PVA AND FASTRACKER-325 INFUSION CATHETER (K030966)Boston Scientific Corp2003-09-23
EMBOSPHERE MICROSPHERES AND EMBOGOLD MICROSPHERES FOR USE IN UTERINE FIBROID EMBOLIZATION (K021397)Biosphere Medical, Inc.2002-11-22

Track NAJ automatically

Every clearance here is in the API, with alerts when new ones post.